Assembly Biosciences, Inc. (ASMB) income statement
ASMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/309% below fair value
$22.39−0.11 (-0.49%)
Close on Nov 18, 2026Market cap $455.87MP/E –Yield –
Assembly Biosciences, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- -11.8%
- Net margin
- -0.1%
- Return on equity, FY2025
- -5.1%
Financial strength
- Current ratio
- 13.99
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 137.7%
Valuation
- P/E ratio
- –
- Price to sales
- 6.09
- Price to book
- 1.49
- Dividend yield
- –
See a number that looks wrong?